{
  "id": 17076550,
  "title": "Genmab's stock rises on cancer data, while Iovance, Coherus tumble",
  "url": "https://urgent.news/2026/10/29/genmabs-stock-rises-on-cancer-data-while-iovance-coherus-tumble",
  "topic": "finance",
  "section": "Finance & Markets",
  "published": "2026-10-29T15:06:45.000Z",
  "source": {
    "name": "Endpoints News",
    "slug": "endpoints-news",
    "url": "https://endpoints.news/genmabs-stock-rises-on-cancer-data-while-iovance-and-coherus-tumble/"
  },
  "original_language": "en",
  "account": null,
  "summary": "Cancer trial news drove a number of stock moves in both directions over the past 24 hours. Here's a summary of key results and their impact: Genmab shares rise on head and neck cancer data: ...",
  "key_points": [],
  "editors_take": null,
  "illustration": null,
  "coverage": {
    "outlets": 1,
    "also_reported_by": []
  },
  "ai_generated": true,
  "disclaimer": "Summaries, key points and the editor’s take are written by software from other outlets’ reporting and may contain errors — always check the linked original."
}